The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study
COVID-19 can cause symptoms that last weeks or months after the infection has gone, with a significant impairment of quality of life. Palmitoylethanolamide (PEA) is a naturally occurring lipid mediator that has an entourage effect on the endocannabinoid system mitigating the cytokine storm. The aim...
Main Authors: | Loredana Raciti, Rosaria De Luca, Gianfranco Raciti, Francesca Antonia Arcadi, Rocco Salvatore Calabrò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/10/3/37 |
Similar Items
-
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies
by: Anna Paola Capra, et al.
Published: (2023-08-01) -
Clinical and Epidemiological Profiles of Primary Healthcare Professionals with COVID-19 Infection and Long COVID: An Observational Study
by: Esperanza Romero-Rodríguez, et al.
Published: (2023-06-01) -
A Scoping Review on Long COVID-19: Physiological and Psychological Symptoms Post-Acute, Long-Post and Persistent Post COVID-19
by: Krishna Mohan Surapaneni, et al.
Published: (2022-11-01) -
A cross-sectional study of persisting symptoms following 2 months post-COVID-19 and risk factors for delayed return to pre-COVID-19 health among patients attending a teaching hospital in Kerala
by: Navina P Chandy, et al.
Published: (2022-01-01) -
Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study
by: Isaac Núñez, et al.
Published: (2023-08-01)